Literature DB >> 15940222

Multi-kinase inhibitors create buzz at ASCO.

Malorye A Branca.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15940222     DOI： 10.1038/nbt0605-639

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  9 in total

Review 1.  Bioinformatics and variability in drug response: a protein structural perspective.

Authors:  Jennifer L Lahti; Grace W Tang; Emidio Capriotti; Tianyun Liu; Russ B Altman
Journal:  J R Soc Interface       Date:  2012-05-02       Impact factor: 4.118

2.  Identification of diaryl 5-amino-1,2,4-oxadiazoles as tubulin inhibitors: the special case of 3-(2-fluorophenyl)-5-(4-methoxyphenyl)amino-1,2,4-oxadiazole.

Authors:  Andrei A Gakh; Andrey V Sosnov; Mikhail Krasavin; Tam Luong Nguyen; Ernest Hamel
Journal:  Bioorg Med Chem Lett       Date:  2013-01-11       Impact factor: 2.823

3.  Drug discovery using chemical systems biology: weak inhibition of multiple kinases may contribute to the anti-cancer effect of nelfinavir.

Authors:  Li Xie; Thomas Evangelidis; Lei Xie; Philip E Bourne
Journal:  PLoS Comput Biol       Date:  2011-04-28       Impact factor: 4.475

4.  In silico design and biological evaluation of a dual specificity kinase inhibitor targeting cell cycle progression and angiogenesis.

Authors:  Antony M Latham; Jayakanth Kankanala; Gareth W Fearnley; Matthew C Gage; Mark T Kearney; Shervanthi Homer-Vanniasinkam; Stephen B Wheatcroft; Colin W G Fishwick; Sreenivasan Ponnambalam
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

5.  Efficacy of the highly selective focal adhesion kinase inhibitor BI 853520 in adenocarcinoma xenograft models is linked to a mesenchymal tumor phenotype.

Authors:  Ulrich A Hirt; Irene C Waizenegger; Norbert Schweifer; Christian Haslinger; Daniel Gerlach; Jürgen Braunger; Ulrike Weyer-Czernilofsky; Heinz Stadtmüller; Ioannis Sapountzis; Gerd Bader; Andreas Zoephel; Bojan Bister; Anke Baum; Jens Quant; Norbert Kraut; Pilar Garin-Chesa; Günther R Adolf
Journal:  Oncogenesis       Date:  2018-02-23       Impact factor: 7.485

6.  Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and in silico studies.

Authors:  Wagdy M Eldehna; Sara T Al-Rashood; Tarfah Al-Warhi; Razan O Eskandrani; Amal Alharbi; Ahmed M El Kerdawy
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

Review 7.  The regulatory role of AP-2β in monoaminergic neurotransmitter systems: insights on its signalling pathway, linked disorders and theragnostic potential.

Authors:  Mohamed H Al-Sabri; Maryam Nikpour; Laura E Clemensson; Misty M Attwood; Michael J Williams; Mathias Rask-Anderson; Jessica Mwinyi; Helgi B Schiöth
Journal:  Cell Biosci       Date:  2022-09-08       Impact factor: 9.584

8.  Discovery of drug-resistant and drug-sensitizing mutations in the oncogenic PI3K isoform p110 alpha.

Authors:  Eli R Zunder; Zachary A Knight; Benjamin T Houseman; Beth Apsel; Kevan M Shokat
Journal:  Cancer Cell       Date:  2008-08-12       Impact factor: 31.743

9.  Computational analysis and predictive modeling of polymorph descriptors.

Authors:  Yugyung Lee; Sourav Jana; Gayathri Acharya; Chi H Lee
Journal:  Chem Cent J       Date:  2013-02-04       Impact factor: 4.215
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.